Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Stock Symbol
-
GLUE on Nasdaq
There are no Buy or Sell transactions made by New Enterprise Associates 17, L.P. since 8/26/2023
Holdings reported by New Enterprise Associates 17, L.P. for Monte Rosa Therapeutics, Inc.
| Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
7.69M |
$146M |
$19.00 |
Jun 28, 2021 |
Direct |
|
|
| Series A-2 convertible preferred stock |
0 |
|
|
Jun 28, 2021 |
Direct |
Common Stock |
|
| Series B convertible preferred stock |
0 |
|
$2.00 |
Jun 28, 2021 |
Direct |
Common Stock |
|
| Series C convertible preferred Stock |
0 |
|
$2.96 |
Jun 28, 2021 |
Direct |
Common Stock |
|
Transactions reported by New Enterprise Associates 17, L.P. for Monte Rosa Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.